Market Tracker

02/16 5:15pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

9.99
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
3.18
Today|||52-Week Range
10.21
+170.00%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close9.99
Today’s open10.00
Day’s range9.97 - 10.00
Volume990,228
Average volume (3 months)698,590
Market cap$505.1M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-820.59%
Earnings growth (this year)+60.22%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.01+0.39%
ARWRArrowhead Pharmaceut...-0.26-4.46%
CDXSCodexis Inc+0.55+6.25%
BCLIBrainstorm Cell Ther...+0.03+0.95%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$57.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts